United therapeutics corp - CL A

Q3 2024 13F Holders as of 9/30/2024

Type / Class
Equity / CL A
Number of holders
1
Total Shares
27.5K
Shares change
+27.5K
Total reported value, excl. options
$9.85M
Value change
+$9.85M
Put/Call ratio
0
Number of buys
1
Number of sells
0
Price
$358.12
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.